Position in VRTX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$657,528,360
+$66,273,933 QoQ
Shares Held
1,472,496
+12.9% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 98.3171431365518.ToString("F0")%
Shared 0.ToString("F0")%
None 1.6828568634481857.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Amundi holds $2,277,505,863 across 70 Biotechnology names. VRTX ranks #2 (28.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,009,798 | $780,210,323 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,472,496 | $657,528,360 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
747,544 | $247,339,881 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,088,773 | $148,168,440 | |
| 5 | INSM |
INSMED Inc
|
804,977 | $131,629,838 | |
| 6 | INCY |
Incyte Corp
|
1,003,969 | $94,493,561 | |
| 7 | MRNA |
Moderna, Inc.
|
904,823 | $45,965,008 | |
| 8 | ARGX |
Argenx SE
|
61,433 | $44,861,448 |
All Filings in VRTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $657,528,360 | 1,472,496 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $591,254,427 | 1,304,161 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $438,233,799 | 1,118,971 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $504,512,210 | 1,133,226 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,502,393,658 | 3,098,869 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,321,341,245 | 3,281,205 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,748,345,463 | 3,759,236 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,642,422,522 | 3,504,059 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,497,764,513 | 3,583,083 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,105,974,617 | 2,718,117 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $675,805,211 | 1,943,421 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $579,187,895 | 1,645,841 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $642,401,885 | 2,038,918 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $615,158,280 | 2,130,197 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $528,503,725 | 1,825,322 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $262,455,535 | 931,387 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $154,624,196 | 592,498 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $180,896,373 | 823,754 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,140,597 | 689,898 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $135,843,365 | 673,726 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||